Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionClearbridge Investments, LLC
Latest Disclosed Ownership7,617 shares
Latest Disclosed Value $ 279,927
Clearbridge Investments, LLC reports 11.62% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 13, 2026 - Clearbridge Investments, LLC filed a 13F-HR form disclosing ownership of 7,617 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $240,316 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 8,618 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -11.62% during the quarter. The current value of the position is $272,841 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F Novo Nordisk A ADR 670100205 7,617 -1,001 -11.62 280 -36.30 0.0002
2026-02-11 2025-12-31 13F Novo Nordisk A ADR 670100205 8,618 -882,035 -99.03 438 -99.11 0.0004
2025-11-13 2025-09-30 13F Novo Nordisk A ADR 670100205 890,653 -7,332,020 -89.17 49,422 -91.29 0.0372
2025-08-12 2025-06-30 13F Novo Nordisk A ADR 670100205 8,222,673 1,588,739 23.95 567,529 23.20 0.4608
2025-05-13 2025-03-31 13F Novo Nordisk A ADR 670100205 6,633,934 2,350,617 54.88 460,660 25.03 0.4025
2025-02-12 2024-12-31 13F Novo Nordisk A ADR 670100205 4,283,317 1,602,549 59.78 368,451 15.43 0.2986
2024-11-12 2024-09-30 13F Novo Nordisk A ADR 670100205 2,680,768 540,054 25.23 319,199 4.46 0.2510
2024-08-27 2024-06-30 13F/A-1 Novo Nordisk A ADR 670100205 2,140,714 -86,103 -3.87 305,565 6.87 0.2482
2024-08-14 2024-06-30 13F Novo Nordisk A ADR 670100205 2,140,714 -86,103 305,565 0.2499
2024-05-13 2024-03-31 13F Novo Nordisk A ADR 670100205 2,226,817 -87,444 -3.78 285,923 19.43 0.2267
2024-02-09 2023-12-31 13F Novo Nordisk A ADR 670100205 2,314,261 89,152 4.01 239,410 18.31 0.2060
2023-11-13 2023-09-30 13F Novo Nordisk A ADR 670100205 2,225,109 907,561 68.88 202,351 -5.10 0.1947
2023-08-11 2023-06-30 13F Novo Nordisk A ADR 670100205 1,317,548 -84,241 -6.01 213,219 -4.42 0.1924
2023-05-12 2023-03-31 13F Novo Nordisk A ADR 670100205 1,401,789 -25,027 -1.75 223,081 15.52 0.2132
2023-02-10 2022-12-31 13F Novo Nordisk A ADR 670100205 1,426,816 443,609 45.12 193,105 97.13 0.1907
2022-11-14 2022-09-30 13F Novo Nordisk A ADR 670100205 983,207 66,977 7.31 97,957 -4.05 0.0988
2022-08-11 2022-06-30 13F Novo Nordisk A ADR 670100205 916,230 -336,878 -26.88 102,095 -26.63 0.0952
2022-05-13 2022-03-31 13F Novo Nordisk A ADR 670100205 1,253,108 -1,385,158 -52.50 139,158 -52.91 0.1046
2022-02-11 2021-12-31 13F Novo Nordisk A ADR 670100205 2,638,266 -106,740 -3.89 295,486 12.12 0.2013
2021-11-12 2021-09-30 13F Novo Nordisk A ADR 670100205 2,745,006 80,560 3.02 263,548 18.08 0.1879
2021-08-13 2021-06-30 13F Novo Nordisk A ADR 670100205 2,664,446 52,097 1.99 223,201 26.73 0.1553
2021-05-13 2021-03-31 13F Novo Nordisk A ADR 670100205 2,612,349 85,433 3.38 176,125 -0.22 0.1313
2021-02-10 2020-12-31 13F Novo Nordisk A ADR 670100205 2,526,916 163,748 6.93 176,505 7.58 0.1363
2020-11-12 2020-09-30 13F Novo Nordisk A ADR 670100205 2,363,168 53,109 2.30 164,075 8.47 0.1410
2020-08-14 2020-06-30 13F NOVO-NORDISK A S ADR 670100205 2,310,059 147,425 6.82 151,263 16.19 0.1366
2020-05-22 2020-03-31 13F/A-1 NOVO-NORDISK A S ADR 670100205 2,162,634 146,914 7.29 130,191 10.67 0.1411
2020-05-15 2020-03-31 13F NOVO-NORDISK A S ADR 670100205 2,162,634 146,914 130,191 141,130.6965
2020-02-14 2019-12-31 13F NOVO-NORDISK A S ADR 670100205 2,015,720 210,689 11.67 117,637 26.06 0.0974
2019-11-14 2019-09-30 13F NOVO-NORDISK A S ADR 670100205 1,805,031 327,836 22.19 93,320 23.77 0.0815
2019-08-14 2019-06-30 13F NOVO-NORDISK A S ADR 670100205 1,477,195 316,253 27.24 75,396 24.15 0.0653
2019-05-15 2019-03-31 13F NOVO-NORDISK A S ADR 670100205 1,160,942 344,989 42.28 60,729 61.55 0.0537
2019-02-14 2018-12-31 13F NOVO-NORDISK A S ADR 670100205 815,953 171,396 26.59 37,591 23.72 0.0380
2018-11-28 2018-09-30 13F/A-1 NOVO-NORDISK A S ADR 670100205 644,557 205,326 46.75 30,384 49.99 0.0262
2018-11-14 2018-09-30 13F NOVO-NORDISK A S ADR 670100205 644,557 205,326 30,384
2018-08-14 2018-06-30 13F NOVO-NORDISK A S ADR 670100205 439,231 64,948 17.35 20,257 9.90 0.0166
2018-05-15 2018-03-31 13F NOVO-NORDISK A S ADR 670100205 374,283 -105,476 -21.99 18,433 -28.41 0.0174
2018-02-14 2017-12-31 13F NOVO-NORDISK A S ADR 670100205 479,759 29,610 6.58 25,749 18.80 0.0238
2017-11-14 2017-09-30 13F NOVO-NORDISK A S ADR 670100205 450,149 28,128 6.67 21,675 19.75 0.0208
2017-08-14 2017-06-30 13F NOVO-NORDISK A S ADR 670100205 422,021 19,368 4.81 18,100 31.13 0.0178
2017-06-07 2017-03-31 13F/A-1 NOVO-NORDISK A S ADR 670100205 402,653 29,133 7.80 13,803 3.05 0.0139
2017-05-15 2017-03-31 13F NOVO-NORDISK A S ADR 670100205 402,653 13,803
2017-02-14 2016-12-31 13F NOVO-NORDISK A S ADR 670100205 373,520 -7,950 -2.08 13,394 -15.58 0.0147
2016-11-14 2016-09-30 13F NOVO-NORDISK A S ADR 670100205 381,470 -217 -0.06 15,865 -22.71 0.0179
2016-08-15 2016-06-30 13F NOVO-NORDISK A S ADR 670100205 381,687 -18,238 -4.56 20,527 -5.28 0.0243
2016-05-16 2016-03-31 13F NOVO-NORDISK A S ADR 670100205 399,925 -48,698 -10.85 21,672 -16.83 0.0259
2016-02-16 2015-12-31 13F NOVO-NORDISK A S ADR 670100205 448,623 15,137 3.49 26,056 10.82 0.0302
2015-11-16 2015-09-30 13F NOVO-NORDISK A S ADR 670100205 433,486 -31,123 -6.70 23,512 -7.59 0.0281
2015-08-17 2015-06-30 13F/A-1 NOVO-NORDISK A S ADR 670100205 464,609 2,363 0.51 25,442 3.09 0.0269
2015-08-14 2015-06-30 13F NOVO-NORDISK A S ADR 670100205 464,609 25,442
2015-05-15 2015-03-31 13F NOVO-NORDISK A S ADR 670100205 462,246 5,096 1.11 24,679 27.56 0.0256
2015-02-17 2014-12-31 13F NOVO-NORDISK A S ADR 670100205 457,150 -430 -0.09 19,347 -11.21 0.0203
2014-11-14 2014-09-30 13F NOVO-NORDISK A S ADR 670100205 457,580 -383 -0.08 21,790 3.01 0.0240
2014-08-14 2014-06-30 13F NOVO-NORDISK A S ADR 670100205 457,963 -2,431 -0.53 21,153 0.65 0.0238
2014-05-15 2014-03-31 13F NOVO-NORDISK A S ADR 670100205 460,394 368,570 401.39 21,017 23.88 0.0249
2014-02-14 2013-12-31 13F NOVO-NORDISK A S ADR 670100205 91,824 18,989 26.07 16,965 37.65 0.0211
2013-11-14 2013-09-30 13F NOVO-NORDISK A S ADR 670100205 72,835 -2,478 -3.29 12,325 5.59 0.0172
2013-08-14 2013-06-30 13F NOVO-NORDISK A S ADR 670100205 75,313 75,313 11,672 0.0178
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.